Asia Medical & Agricultural Laboratory & Research Center PCL
Asia Medical & Agricultural Laboratory & Research Center PCL provides industrial services, primarily through its operations in the business support services sector.
Business. Asia Medical & Agricultural Laboratory & Research Center PCL (AMARCM.BK) is a provider of business support services operating within the Industrial & Commercial Services sector. The company is headquartered in Thailand and is primarily listed on the Stock Exchange of Thailand (SET). Specific details regarding its operating segments and geographic revenue mix are not available.
Analyst recommendations
1 analysts · consensus HoldAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Asia Medical & Agricultural Laboratory & Research Center PCL (AMARCM.BK) is a provider of business support services operating within the Industrial & Commercial Services sector. The company is headquartered in Thailand and is primarily listed on the Stock Exchange of Thailand (SET). Specific details regarding its operating segments and geographic revenue mix are not available.
Asia Medical & Agricultural Laboratory & Research Center PCL maintains a strong liquidity position, with a current ratio of 4.78 and a cash and equivalents balance of 45.56 million THB. The company's debt-to-equity ratio is 0.03, indicating a conservative capital structure with minimal leverage. Free cash flow of 149.95 million THB supports operational flexibility and potential reinvestment.
Profitability metrics show a return on equity of 26.34% and a return on assets of 22.48%, both significantly above the typical thresholds for the Business Support Services industry. The operating margin, calculated as operating income of 158.27 million THB divided by revenue of 491.01 million THB, is 32.23%, which is robust compared to industry medians.
The company's revenue is concentrated in a single disclosed segment, with no geographic breakdown provided in the latest financial data. This lack of diversification may expose the company to regional economic fluctuations, though the specific impact is not quantified in the available data.
Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant revenue deltas reported in the outlook. Historical revenue of 491.01 million THB provides a baseline for future performance, though the absence of forward-looking guidance limits the ability to assess long-term growth potential.
Risk factors are minimal, with low liquidity and dilution risk scores. No immediate filing-based liquidity or dilution flags were detected, and the company has not issued any recent dilutive instruments. The absence of dilution pressure is supported by the identical basic and diluted share counts of 420 million shares.
Recent events include a single analyst recommendation of "Hold" with a mean price target of 4.30 THB. No strong buy or buy ratings were issued, and the company has not disclosed any material events in its recent filings or transcripts that would suggest a significant shift in business strategy or performance.
- Asia Medical & Agricultural Laboratory & Research Center PCL has a strong liquidity position with a current ratio of 4.78 and a low debt-to-equity ratio of 0.03.
- The company demonstrates high profitability, with a return on equity of 26.34% and a return on assets of 22.48%.
- Revenue is concentrated in a single segment, with no geographic diversification disclosed, potentially increasing exposure to regional economic risks.
- Analysts have issued a "Hold" recommendation with a mean price target of 4.30 THB, indicating a neutral outlook.
- The company faces minimal liquidity and dilution risks, with no immediate filing-based flags detected.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,39 |
| Revenue | —no estimate | —no estimate | 525,0M THB |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Asia Medical & Agricultural Laboratory & Research Center PCL Market data — financials · 2026-05-27
- Asia Medical & Agricultural Laboratory & Research Center PCL Market data — analyst estimates · 2026-05-27